Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry

被引:22
作者
Cermakova, Pavla [1 ,2 ,3 ]
Fereshtehnejad, Seyed-Mohammad [4 ]
Johnell, Kristina [5 ,6 ]
Winblad, Bengt [1 ,7 ]
Eriksdotter, Maria [4 ,7 ]
Religa, Dorota [1 ,7 ]
机构
[1] Karolinska Inst, Div Neurogeriatr, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, S-14157 Huddinge, Sweden
[2] Int Clin Res Ctr, Brno 65691, Czech Republic
[3] St Annes Univ Hosp, Brno 65691, Czech Republic
[4] Karolinska Inst, Div Clin Geriatr, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, S-14157 Huddinge, Sweden
[5] Karolinska Inst, Aging Res Ctr, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, S-11330 Stockholm, Sweden
[6] Stockholm Univ, S-11330 Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Geriatr Med, S-14186 Huddinge, Sweden
关键词
VASCULAR RISK-FACTORS; CONVERTING ENZYME-INHIBITORS; ALZHEIMERS-DISEASE; LEWY BODIES; PARKINSONS-DISEASE; DRUG-THERAPY; FRONTOTEMPORAL DEMENTIA; ANTIHYPERTENSIVE DRUGS; COGNITIVE IMPAIRMENT; ANGIOTENSIN SYSTEM;
D O I
10.1186/alzrt264
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Administration of several cardiovascular drugs has an effect on dementia. We aimed to investigate whether there are differences in the use of cardiovascular medication between different dementia disorders. Methods: We obtained information about dementia patients from the Swedish Dementia Registry. Patients were diagnosed with one of these dementia disorders: Alzheimer's disease (n = 8,139), mixed dementia (n = 5,203), vascular dementia (n = 4,982), Lewy body dementia (n = 605), frontotemporal dementia (n = 409) and Parkinson's disease dementia (n = 405). Multivariate logistic regression analysis was performed to investigate the association between use of cardiovascular medication and dementia disorders, after adjustment for age, gender, living alone, cognitive status and total number of drugs (a proxy for overall co-morbidity). Results: Seventy percent of all the dementia patients used cardiovascular medication. Use of cardiovascular drugs is common in patients with vascular and mixed dementia. Male gender, higher age, slightly better cognitive status and living with another person was associated with use of cardiovascular medication. Conclusions: Cardiovascular medication is used extensively across dementia disorders and particularly in vascular and mixed dementia. Future research should investigate the tolerability and effectiveness of these drugs in the different dementia disorders.
引用
收藏
页数:9
相关论文
共 67 条
[11]   Aldosterone synergizes with peripheral inflammation to induce brain IL-1β expression and depressive-like effects [J].
Bay-Richter, Cecilie ;
Hallberg, Ludvig ;
Ventorp, Filip ;
Janelidze, Shorena ;
Brundin, Lena .
CYTOKINE, 2012, 60 (03) :749-754
[12]   Risk factors for dementia with Lewy bodies A case-control study [J].
Boot, Brendon P. ;
Orr, Carolyn F. ;
Ahlskog, J. Eric ;
Ferman, Tanis J. ;
Roberts, Rosebud ;
Pankratz, Vernon S. ;
Dickson, Dennis W. ;
Parisi, Joseph ;
Aakre, Jeremiah A. ;
Geda, Yonas E. ;
Knopman, David S. ;
Petersen, Ronald C. ;
Boeve, Bradley F. .
NEUROLOGY, 2013, 81 (09) :833-840
[13]   Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - Implications for pay for performance [J].
Boyd, CM ;
Darer, J ;
Boult, C ;
Fried, LP ;
Boult, L ;
Wu, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06) :716-724
[14]   Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reports [J].
Brunnstrom, Hans ;
Gustafson, Lars ;
Passant, Ulla ;
Englund, Elisabet .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 49 (01) :146-149
[15]   Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease [J].
Dong, Yi-Fei ;
Kataoka, Keiichiro ;
Tokutomi, Yoshiko ;
Nako, Hisato ;
Nakamura, Taishi ;
Toyama, Kensuke ;
Sueta, Daisuke ;
Koibuchi, Nobutaka ;
Yamamoto, Eiichiro ;
Ogawa, Hisao ;
Kim-Mitsuyama, Shokei .
FASEB JOURNAL, 2011, 25 (09) :2911-2920
[16]   Living alone with dementia [J].
Duane, Fleur ;
Brasher, Kathleen ;
Koch, Susan .
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE, 2013, 12 (01) :123-136
[17]   Alzheimer's disease or other dementia and medical care utilization [J].
Eaker, ED ;
Mickel, SF ;
Chyou, PH ;
Mueller-Rizner, NJ ;
Slusser, JP .
ANNALS OF EPIDEMIOLOGY, 2002, 12 (01) :39-45
[18]  
Fereshtehnejad SM, 2014, DRUGS AGING, V2014, P2014, DOI DOI 10.1007/S40266-014-0154-8
[19]   Medication management for people with dementia in primary care: description of implementation in the DelpHi study [J].
Fiss, Thomas ;
Thyrian, Jochen Rene ;
Wucherer, Diana ;
Assmann, Grit ;
Kilimann, Ingo ;
Teipel, Stefan J. ;
Hoffmann, Wolfgang .
BMC GERIATRICS, 2013, 13
[20]   Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial [J].
Forette, F ;
Seux, ML ;
Staessen, JA ;
Thijs, L ;
Birkenhäger, WH ;
Babarskiene, MR ;
Babeanu, S ;
Bossini, A ;
Gil-Extremera, B ;
Girerd, X ;
Laks, T ;
Lilov, E ;
Moisseyev, V ;
Tuomilehto, J ;
Vanhanen, H ;
Webster, J ;
Yodfat, Y ;
Fagard, R .
LANCET, 1998, 352 (9137) :1347-1351